Morphic therapeutic to present at the jefferies virtual healthcare conference

Waltham, mass., may 28, 2021 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of the morphic leadership team are scheduled to present at the jefferies virtual healthcare conference on june 4, 2021 at 9:00 am et.
MORF Ratings Summary
MORF Quant Ranking